Recurrence of primary sclerosing cholangitis, primary biliary cholangitis and auto-immune hepatitis after liver transplantation.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Best practice & research. Clinical gastroenterology

• Publication date

  2017-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.bpg.2017.04.004PMID 28624107
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A microbial signature for Crohn's disease

  2017cited by this paper
• Systematic review: recurrent autoimmune liver diseases after liver transplantation

  2017cited by this paper
• Management of cholestatic disease in 2017

  2017cited by this paper
• 'De novo' and 'recurrent' autoimmune hepatitis after liver transplantation: A comprehensive review.

  2016cited by this paper
• Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease

  2016cited by this paper
• First‐Degree Living‐Related Donor Liver Transplantation in Autoimmune Liver Diseases

  2016cited by this paper
• Recurrent primary sclerosing cholangitis in the Adult‐to‐Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients

  2016influential reference
• Autoimmune Liver Disease Post-Liver Transplantation: A Summary and Proposed Areas for Future Research

  2016cited by this paper
• Gut-liver immunity.

  2016cited by this paper
• Longterm corticosteroid use after liver transplantation for autoimmune hepatitis is safe and associated with a lower incidence of recurrent disease

  2016cited by this paper
• The natural history of inflammatory bowel disease and primary sclerosing cholangitis after liver transplantation – a single-centre experience

  2016influential reference
• Long‐Term Outcomes of Living‐Donor Liver Transplantation for Primary Biliary Cirrhosis: A Japanese Multicenter Study

  2016cited by this paper
• Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: A retrospective multicenter analysis

  2016influential reference
• Risk factors for recurrent primary sclerosing cholangitis after liver transplantation.

  2015influential reference
• Autoimmunity after liver transplantation: a frequent event but a rare clinical problem

  2015cited by this paper
• Preventive administration of UDCA after liver transplantation for primary biliary cirrhosis is associated with a lower risk of disease recurrence.

  2015cited by this paper
• Recurrence of autoimmune liver diseases after liver transplantation.

  2015cited by this paper
• Changing Nomenclature for PBC: From 'Cirrhosis' to 'Cholangitis'.

  2015cited by this paper
• Changing nomenclature for PBC: from ‘cirrhosis’ to ‘cholangitis’

  2015cited by this paper
• Changing nomenclature for PBC: from 'cirrhosis' to 'cholangitis'.

  2015cited by this paper
• Autoimmune liver disease, autoimmunity and liver transplantation.

  2014cited by this paper
• Hepatic ischemia and reperfusion injury: effects on the liver sinusoidal milieu.

  2013cited by this paper
• Update on primary sclerosing cholangitis.

  2013cited by this paper
• Calcineurin Inhibitors and the IL12A Locus Influence Risk of Recurrent Primary Biliary Cirrhosis After Liver Transplantation

  2013cited by this paper
• Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management.

  2013cited by this paper
• Liver Transplantation for Perihilar Cholangiocarcinoma

  2013cited by this paper
• Role of the intestinal microbiome in liver disease.

  2013cited by this paper
• Excellent quality of life after liver transplantation for patients with perihilar cholangiocarcinoma who have undergone neoadjuvant chemoradiation

  2013cited by this paper
• Liver transplantation for overlap syndromes of autoimmune liver diseases

  2013cited by this paper
• Liver transplantation and autoimmune liver diseases

  2013cited by this paper
• Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers.

  2012cited by this paper
• Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR).

  2012cited by this paper
• Diagnosis, Pathogenesis, and Treatment of Autoimmune Hepatitis After Liver Transplantation

  2012influential reference
• Recurrence of autoimmune liver diseases after liver transplantation: clinical aspects

  2012cited by this paper
• Posttransplant biliary complications in the pre‐ and post‐model for end‐stage liver disease era

  2011cited by this paper
• Liver transplantation in PBC and PSC: indications and disease recurrence.

  2011cited by this paper
• Risk Factors for Recurrence of Primary Sclerosing Cholangitis after Living Donor Liver Transplantation in Japanese Registry

  2011influential reference
• Long-term outcomes of patients with autoimmune hepatitis managed at a nontransplant center.

  2011cited by this paper
• Liver transplantation in autoimmune liver diseases.

  2011cited by this paper
• Recurrent Primary Biliary Cirrhosis After Liver Transplantation

  2010cited by this paper
• Population‐based epidemiology study of autoimmune hepatitis: A disease of older women?

  2010cited by this paper
• Cyclosporine A Protects Against Primary Biliary Cirrhosis Recurrence After Liver Transplantation

  2010cited by this paper
• Update on primary sclerosing cholangitis.

  2010cited by this paper
• Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in sweden

  2010cited by this paper
• Primary biliary cirrhosis after liver transplantation: Influence of immunosuppression and human leukocyte antigen locus disparity

  2010influential reference
• Diagnosis and management of primary sclerosing cholangitis

  2010cited by this paper
• The natural history of inflammatory bowel disease and primary sclerosing cholangitis after liver transplantation--a single-centre experience.

  2010cited by this paper
• Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis.

  2010cited by this paper
• Living Donor and Deceased Donor Liver Transplantation for Autoimmune and Cholestatic Liver Diseases—An Analysis of the UNOS Database

  2010cited by this paper
• Comparative Analysis of Outcomes in Living and Deceased Donor Liver Transplants for Primary Sclerosing Cholangitis

  2009cited by this paper
• Risk factors for recurrence of autoimmune hepatitis after liver transplantation

  2009influential reference
• A re‐evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts

  2009cited by this paper
• High‐dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

  2009cited by this paper
• Recurrence of primary biliary cirrhosis and development of autoimmune hepatitis after liver transplant: A blind histologic study

  2009cited by this paper
• EASL Clinical Practice Guidelines: management of cholestatic liver diseases.

  2009cited by this paper
• Clinically recurrent primary sclerosing cholangitis following liver transplantation: A time course

  2008cited by this paper
• The impact of disease recurrence on graft survival following liver transplantation: a single centre experience

  2008cited by this paper
• Liver transplantation for autoimmune hepatitis and the success of aggressive corticosteroid withdrawal

  2008cited by this paper
• Long‐term outcome of human leukocyte antigen mismatching in liver transplantation: Results of the national institute of diabetes and digestive and kidney diseases liver transplantation database

  2008cited by this paper
• Risk of Primary Sclerosing Cholangitis and Ulcerative Colitis in irst-Degree Relatives of Patients With Primary Sclerosing Cholangitis

  2008cited by this paper
• Simplified criteria for the diagnosis of autoimmune hepatitis

  2008cited by this paper
• Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation

  2008cited by this paper
• Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation

  2008influential reference
• Transplantation trends in primary biliary cirrhosis.

  2007cited by this paper
• Recurrence of primary biliary cirrhosis and primary sclerosing cholangitis after liver transplantation in Japan

  2007cited by this paper
• High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

  2007cited by this paper
• Immunohistochemical analysis of inflammation in primary sclerosing cholangitis

  2007cited by this paper
• Long‐term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation

  2007influential reference
• Recurrence of autoimmune liver disease after liver transplantation: A systematic review

  2006cited by this paper
• Long‐term follow‐up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients

  2006influential reference
• Liver biopsy interpretation for causes of late liver allograft dysfunction

  2006cited by this paper
• Recurrent primary biliary cirrhosis: Peritransplant factors and ursodeoxycholic acid treatment post‐liver transplant

  2005influential reference
• Recurrent primary sclerosing cholangitis after liver transplantation: A magnetic resonance cholangiography study with analyses of predictive factors

  2005cited by this paper
• Long-Term Outcome of Liver Transplantation in Patients With PSC: A Comparative Analysis With PBC

  2004cited by this paper
• Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantation

  2004cited by this paper
• The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation

  2003cited by this paper
• Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation

  2003cited by this paper
• Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community.

  2003cited by this paper
• Recurrent primary biliary cirrhosis

  2003cited by this paper
• A 10 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence

  2003influential reference
• Liver transplantation for primary sclerosing cholangitis: a long-term clinicopathologic study.

  2003cited by this paper
• Liver transplantation for primary biliary cirrhosis: A long‐term pathologic study

  2003cited by this paper
• Recurrence of primary biliary cirrhosis after liver transplantation: Histologic estimate of incidence and natural history

  2003cited by this paper
• Liver Transplantation for Nonviral, Nonmalignant Diseases:Problem of Recurrence

  2002cited by this paper
• Incidence and recurrence of autoimmune/alloimmune hepatitis in liver transplant recipients

  2002influential reference
• Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population

  2002cited by this paper
• BENEFIT OF TRANSPLANTATION IN PRIMARY BILIARY CIRRHOSIS BETWEEN 1985-1997

  2002cited by this paper
• Risk factors for recurrence of primary sclerosing cholangitis of liver allograft.

  2002cited by this paper
• Recurrent autoimmune hepatitis after orthotopic liver transplantation

  2001influential reference
• Recurrent autoimmune hepatitis after liver transplantation: Diagnostic criteria, risk factors, and outcome

  2001cited by this paper
• Disease recurrence after living liver transplantation for primary biliary cirrhosis: A clinical and histological follow‐up study

  2001cited by this paper
• Outcome after liver transplantation for primary sclerosing cholangitis.

  2001cited by this paper
• Primary sclerosing cholangitis

  2001cited by this paper
• Transplantation for primary biliary cirrhosis: Retrospective analysis of 400 patients in a single center

  2001influential reference
• Liver transplantation for autoimmune hepatitis: A long‐term pathologic study

  2000influential reference
• Liver transplantation for autoimmune hepatitis

  2000influential reference
• Increased incidence of chronic rejection in adult patients transplanted for autoimmune hepatitis: assessment of risk factors.

  2000cited by this paper
• [Primary sclerosing cholangitis].

  2000cited by this paper
• Long‐term results of patients undergoing liver transplantation for primary sclerosing cholangitis

  1999cited by this paper
• Recurrence of autoimmune hepatitis after liver transplantation.

  1999cited by this paper

• CCL24 and Fibrosis: A Narrative Review of Existing Evidence and Mechanisms

  2025cites this paper
• Global epidemiology and determinants of autoimmune hepatitis recurrence post- liver transplantation: A systematic review and meta-analysis.

  2025cites this paper
• Recurrence of primary sclerosing cholangitis after liver transplantation: a French national cohort study including 571 patients.

  2025cites this paper
• Utilizing Machine Learning to Predict Liver Allograft Fibrosis by Leveraging Clinical and Imaging Data

  2025cites this paper
• Integration of molecular testing with clinical criteria and histopathology improves diagnostic precision in immune-mediated liver diseases.

  2025cites this paper
• The Impact of Biliary Injury on the Recurrence of Biliary Cancer and Benign Disease after Liver Transplantation: Risk Factors and Mechanisms

  2024cites this paper
• S2k-Leitlinie Lebertransplantation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV)

  2024cites this paper
• The Swedish initiative for the study of Primary sclerosing cholangitis (SUPRIM)

  2024cites this paper
• Evolving challenges with long‐term care of liver transplant recipients

  2023cites this paper
• A Comprehensive Review of Liver Allograft Fibrosis and Steatosis: From Cause to Diagnosis

  2023cites this paper
• Liver allograft pathology in the late post-transplant period

  2023cites this paper
• European Society for Organ Transplantation Consensus Statement on Biomarkers in Liver Transplantation

  2023cites this paper
• Treatment of Autoimmune Hepatitis.

  2023cites this paper
• Cholestasis: exploring the triangular relationship of gut microbiota-bile acid-cholestasis and the potential probiotic strategies

  2023cites this paper
• Characteristics and impact of sex in a cohort of patients with primary sclerosing cholangitis: Experience of a transplant centre in the Mediterranean basin

  2022cites this paper
• Relapse of autoimmune diseases after liver transplantation

  2022cites this paper
• Inflammatory conditions play a role in recurrence of PSC after liver transplantation: An international multicentre study

  2022cites this paper
• CAQ Corner: Disease Recurrence After Liver Transplantation.

  2022influential citation
• Value of posttransplant protocol biopsies in 2 biliary autoimmune liver diseases

  2022cites this paper
• Characteristics and impact of sex in a cohort of patients with primary sclerosing cholangitis: experience of a transplant center in the Mediterranean basin.

  2021cites this paper
• The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis

  2021cites this paper
• Recurrence of primary sclerosing cholangitis after liver transplantation – analysing the European Liver Transplant Registry and beyond

  2021cites this paper
• Autoimmune liver diseases, hepatocellular carcinoma, and recurrence of autoimmunity post-liver transplantation

  2021cites this paper
• Posttransplant immune-mediated cholangiopathies

  2021cites this paper
• Colangitis esclerosante primaria. Una revisión narrativa

  2020cites this paper
• Single-Center North American Experience of Liver Transplantation in Autoimmune Hepatitis: Infrequent Indication but Good Outcomes for Patients

  2020influential citation
• Non-alcoholic fatty liver disease after liver transplantation in patients with non-alcoholic steatohepatitis and cryptogenic cirrhosis: the impact of pre-transplant graft steatosis.

  2020cites this paper
• Treatment of primary biliary cirrhosis with ursodeoxycholic acid combined with traditional Chinese medicine

  2020cites this paper
• Recurrence of primary sclerosing cholangitis after liver transplantation is associated with specific changes in the gut microbiome pretransplant – a pilot study

  2020cites this paper
• Cholestatic Liver Diseases: A Primer for Generalists and Subspecialists.

  2020cites this paper
• A protocol for systematic review and meta-analysis

  2020cites this paper
• The Potentiality of Herbal Remedies in Primary Sclerosing Cholangitis: From In Vitro to Clinical Studies

  2020cites this paper
• Autoimmune Hepatitis: 2019 Update

  2020cites this paper
• Prognosis and Treatment of Primary Biliary Cholangitis : a new name – a new era

  2020cites this paper
• Recurrent Autoimmune Liver Disease and its Scientific Significance

  2020cites this paper
• Effects of Antibiotic Therapy in Primary Sclerosing Cholangitis with and without Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

  2019cites this paper
• Recurrence of disease following organ transplantation in autoimmune liver disease and systemic lupus erythematosus.

  2019cites this paper
• Clinical Management of Primary Biliary Cholangitis—Strategies and Evolving Trends

  2019cites this paper
• Sekundär sklerosierende Cholangitis bei kritisch Kranken

  2019cites this paper
• Liver Surgery in Patients With Inflammatory Bowel Disease

  2019cites this paper
• Primary Biliary Cholangitis and Autoimmune Hepatitis.

  2018cites this paper
• Primary Biliary Cholangitis in Motion Meeting

  2018cites this paper
• Etiopathogenesis of autoimmune hepatitis.

  2018cites this paper
• Improving prognosis in primary biliary cholangitis - Therapeutic options and strategy.

  2018cites this paper
• Primary Biliary Cholangitis Guidance Update: Implications for Liver Transplantation

  2018cites this paper
• How to improve long‐term outcome after liver transplantation?

  2018cites this paper
• Gastrointestinal Manifestations of Autoimmune Diseases Requiring Critical Care.

  2017cites this paper